Our data indicated that OCA treatment repressed the activation of JAK2/STAT3 pathway in colon cancer cells, which was further confirmed by IF staining, showing increased levels of STAT3 protein located in the cell cytoplasm. This evidence concerns the gene STAT3 and malignant colon neoplasm.